Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.70m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Transaction in Own Shares

24 May 2022 17:31

RNS Number : 6688M
Science Group PLC
24 May 2022
 

 

24 May 2022

 

Science Group plc

(the "Company" or "Science Group")

 

Transaction in own shares

 

Science Group plc (AIM:SAG) announces that, on 24 May 2022, it purchased 4,709 of its 1 pence ordinary shares at an average price of 402.0270 pence per share. The highest price paid per share was 405.0 pence and the lowest price paid per share was 398.0 pence. The Company purchased these shares through Liberum Capital Limited.

 

The number of shares purchased represented 0.01% of the voting rights attributable to the total ordinary shares in issue prior to the purchase. The purchased shares will be held in treasury.

 

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 45,503,490. Science Group holds 682,384 shares in treasury and a further 104,400 shares are held by the Frontier Smart Technologies Employee Benefit Trust. The total number of voting rights in the Company following this announcement is therefore 45,399,090.

 

The figure of 45,399,090 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.

 

Schedule of Purchases - Individual Transactions

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Liberum Capital Limited on behalf of the Company as part of the buyback programme.

 

Number of shares purchased

Transaction price (per share)

Time of transaction

Execution venue

1209

2000

500

1000

405.0

398.0

405.0

405.0

13:15:34

16:25:21

16:27:40

16:27:51

AIMX

AIMX

AIMX

AIMX

 

 

- Ends -

 

For further information:

Science Group plc

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

www.sciencegroup.com  

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

Nick Adams, Alex Price, Richard Short

Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Joint Broker)

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBKQBNABKDKPB
Date   Source Headline
26th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSHolding(s) in Company
19th Jun 20257:00 amRNSRicardo Investment and Share Buy-Back
17th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20251:45 pmRNSForm 8.3 - Ricardo plc
11th Jun 202511:00 amRNSHolding(s) in Company
11th Jun 20257:20 amRNSRicardo Investment Realisation
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:01 amRNS-RRicardo EGM – ISS Recommendation
2nd Jun 20257:00 amRNSTotal Voting Rights
28th May 202511:03 amRNSHolding(s) in Company
28th May 20257:00 amRNSRicardo Investment and Open Letter
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 202510:30 amRNSResult of AGM
21st May 20257:01 amRNSAGM Update
21st May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:01 amRNSTreasury shares issued
12th May 20257:00 amRNSIssue of share options and PDMR dealing
8th May 20257:00 amRNSTransaction in Own Shares
1st May 20257:34 amRNSRicardo Investment Update and GM Requisition
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:01 amRNSQ1 Trading Update and Response to Ricardo BSU
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSNotice of Annual General Meeting
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 202510:03 amRNSHolding(s) in Company
8th Apr 20257:01 amRNSShareholding in Ricardo over 20%
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 202512:05 pmRNSExecutive Chair Share Purchase
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 202512:05 pmRNSHolding(s) in Company
4th Apr 20257:00 amRNSIncreased Shareholding in Ricardo plc
3rd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:01 amRNSIncreased Shareholding in Ricardo plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.